Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapy.

MLA

Diraimondo, Thomas R., et al. “Interferon-γ Activates Transglutaminase 2 via a Phosphatidylinositol-3-Kinase-Dependent Pathway: Implications for Celiac Sprue Therapy.” The Journal of Pharmacology and Experimental Therapeutics, vol. 341, no. 1, Apr. 2012, pp. 104–14. EBSCOhost, https://doi.org/10.1124/jpet.111.187385.

APA

Diraimondo, T. R., Klöck, C., & Khosla, C. (2012). Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapy. The Journal of Pharmacology and Experimental Therapeutics, 341(1), 104–114. https://doi.org/10.1124/jpet.111.187385

Chicago

Diraimondo, Thomas R, Cornelius Klöck, and Chaitan Khosla. 2012. “Interferon-γ Activates Transglutaminase 2 via a Phosphatidylinositol-3-Kinase-Dependent Pathway: Implications for Celiac Sprue Therapy.” The Journal of Pharmacology and Experimental Therapeutics 341 (1): 104–14. doi:10.1124/jpet.111.187385.